AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HIV Epitopes Found In Persistently Seronegative Sex Workers Could Aid Vaccine Development.(Brief Article)

Vaccine Weekly

| May 23, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 MAY 23 - (NewsRx.com & NewsRx.net) --

An ideal AIDS vaccine might be one that stimulates the cellular immune system so efficiently that, despite repeated exposure to HIV, an individual never shows signs of viremia or even seroconverts against HIV epitopes.

It is still far from clear how to provide anyone this level of protection, but accumulating data from a cohort of at-risk women - sex workers in the AIDS-ravaged community of Nairobi - hint at some of the properties of an immune system that can apparently repel the virus despite ongoing exposure.

Rupert Kaul at the University of Nairobi and the Weatherall Institute of Molecular Medicine at John Radcliffe Hospital, Oxford, U.K., along with colleagues at those institutions and in Canada, have followed this group for some years, and they have found that persistently seronegative women seem to be protected by a vigorous T-cell-mediated response to infected cells, while those who have seroconverted eventually succumb to the disease.

These ...

Related articles from newspapers, magazines, journals, and more
Neutralizing HIV epitopes available in newly-infected patients.
Newspaper article from: AIDS Weekly May 10, 2004 700+ words
2004 MAY 10 - (NewsRx.com & NewsRx.net) -- Neutralizing HIV epitopes are available in newly-infected patients. According to published research from the United States, England, and Zambia...
Epitope-Based Vaccine Promising for HIV Treatment and Prevention.
Press release article from: Business Wire January 14, 1999 700+ words
...demonstrated the effective delivery of multiple human HIV epitopes using the EpiGene construct, a DNA vector encoding...epitope sequences. The results showed that multiple HIV epitopes, specific for different HIV antigens, could simultaneously...
Why do some patients with HIV live longer, healthier lives?
Newspaper article from: AIDS Alert December 1, 1992 700+ words
...healthy long-term positives have cytotoxic lymphocytes directed against specific proteins or subregions of proteins called HIV epitopes that cause HIV mutation. Understanding the role of cytotoxic responses is an integral part of developing safe and effective...
Research from S. Gaseitsiwe and co-researchers in the area of HIV/AIDS...
Newspaper article from: AIDS Vaccine Week June 8, 2009 700+ words
...molecule-peptide microarray binding assay and evaluated 346 peptides from already identified human immunodeficiency virus (HIV) epitopes and an additional set (n = 206) of 20-mer peptides, overlapping by 15 amino acid residues, from HIV type 1B (HIV...
Dendrites cross-present HIV antigens from live and apoptotic infected CD4+...
Newspaper article from: AIDS Weekly June 28, 2004 700+ words
...infected CD4+ cells. "A better understanding of the antigen presentation pathways that lead to CD8+ T cell recognition of HIV epitopes in vivo is needed to achieve better immune control of HIV replication. "Here, we show that cross-presentation of very...
Other News To Note.
Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...Immunizing mice demonstrated a four- to sixfold enhancement of Th1 cells by Ii-key/antigenic epitope HIV hybrids than HIV epitopes alone, as measured by an immunological assay specific for T-helper cells. o Geospiza Inc., of Seattle, released its...
>TI EUROPEAN PATENT DISCLOSURES Published Aug. 26 (EPO); Aug. 20 (WO).
Magazine article from: BIOWORLD Today November 23, 1998 700+ words
...IX; for production in milk. American Red Cross WO 98/36087 HIV immunological tolerance Falls Church, Va. Fusions of HIV epitopes with immunoglobulins; for inducing tolerance in uninfected cells. Amrad Operations WO 98/36054 Testicular cancer marker...
Investigators at St. George's University target HIV/AIDS.
Newspaper article from: AIDS Vaccine Week August 4, 2008 700+ words
...immune activation are required, as is investigation into the clinical and immunological influence of antibodies that target HIV epitopes associated with disease and that are not necessarily neutralising," wrote M. Cadogan and colleagues, St. George's...
For more facts and information, see all results

Source: HighBeam Research, HIV Epitopes Found In Persistently Seronegative Sex Workers Could Aid...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA